NeoGenomics, Inc. announced the launch of PanTracer Tissue, a next-generation solid tumor profiling assay, including the option to add testing for homologous recombination deficiency...
Streptococcus agalactiae, also known as Group B strep (GBS), is a Gram-positive colonizing bacterium that can cause life-threatening complications for newborns when it is passed...
Indiana University School of Medicine professor Jeff Dage, PhD’s research aided the Food and Drug Administration (FDA) clearance of Fujirebio’s Lumipulse G pTau 217...
The first national proficiency testing program to help laboratories detect and accurately identify the H5N1 strain of bird flu will be delivered this fall, according to the College...
Recent Mayo Clinic research supports the reliability of the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio for diagnosing Alzheimer's, according to a release. The test,...
Maine Molecular Quality Controls has released the Birlinn CoV2-Flu-RSV Control Panel M509, intended for use as a quality control to monitor the performance of in vitro laboratory...
One of the largest real-world studies of a sepsis diagnostic reveals that Cytovale’s IntelliSep, a U.S. Food and Drug Administration (FDA)-cleared rapid host response diagnostic...
LVIS Corp announced the upcoming U.S. release of NeuroMatch Elite.NeuroMatch Elite launches with two capabilities - Seizure Source Localization and Spike Source Localization. ...
Diasorin announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LIAISON PLEX Gram-Positive Blood Culture Assay, the final syndromic...
QIAGEN announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials...
Foresight Diagnostics announced a strategic, worldwide partnership with QIAGEN to develop and commercialize a kit-based version of Foresight’s CLARITY assay, with the goal...